Measuring the risk of clinical adverse events (RISK ACE) by quantifying liver function: A patient-centric model

Eur J Intern Med. 2024 Dec 4:S0953-6205(24)00493-X. doi: 10.1016/j.ejim.2024.11.029. Online ahead of print.

Authors

John Kittelson¹, Michael P McRae², Gregory T Everson³

Affiliations

¹ Consultant to HepQuant, LLC, Denver, CO, USA.
² Custom DX Solutions LLC, Houston, TX, USA.
³ HepQuant, LLC, Denver, CO, USA. Electronic address: [email protected].

PMID: 39638649
DOI: 10.1016/j.ejim.2024.11.029

No abstract available

Keywords: Cirrhosis; Clinical outcome; Compensated advanced chronic liver disease; Liver function testing; Risk prediction.

Publication types

Letter